Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach crawled time : 19:00 save search
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | News | $2.005 -1.72% -1.75% 520K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
cell meeting therapeutics therapy
Nexcella, an Immix Biopharma Subsidiary, on Track to Dose NXC-201 Patients in United States
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
IMMX | News | $2.25 -10.0% -11.11% 190K
|
|
| O: -3.6%
H: 0.0%
C: 0.0%
nxc-201 biopharma
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
STAA | $46.79 0.97% 0.96% 380K
|
Health Technology
|
| O: 12.52%
H: 6.73%
C: 3.53%
sales first
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: -0.29%
H: 7.52%
C: 3.39%
conference therapeutics
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
LBPH | $18.01 5.94% 5.61% 500K
|
Manufacturing
|
| O: -0.61%
H: 0.61%
C: -7.83%
pharmaceuticals meeting study
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 19:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
INBX | $34.47 -0.41% -0.41% 420K
|
Health Technology
|
| O: -0.86%
H: 0.13%
C: -5.66%
year financial results
Arrowhead Pharmaceuticals Announces Pricing of $450.0 Million Underwritten Offering of Common Stock
Published: 2024-01-03 (Crawled : 19:00) - biospace.com/
ARWR | $22.62 0.4% 0.4% 1.3M
|
Health Technology
|
| O: 5.29%
H: 5.07%
C: -2.08%
million offering pharmaceuticals
Masimo to Present in Piper Sandler 35th Annual Healthcare Conference
Published: 2023-11-27 (Crawled : 19:00) - biospace.com/
MASI | $135.91 -0.52% -0.52% 240K
|
Health Technology
|
| O: -0.68%
H: 2.75%
C: 1.98%
conference
Acadia Pharmaceuticals Initiates Phase 2 Clinical Trial of ACP-204 for the Treatment of Alzheimer’s Disease Psychosis
Published: 2023-11-27 (Crawled : 19:00) - biospace.com/
ACAD | $17.08 -0.64% -0.64% 990K
|
Health Technology
|
| O: -0.45%
H: 0.41%
C: -0.32%
acp-204 disease alzheimer’s treatment pharmaceuticals trial phase 2
NEURELIS SECURES NEW ORANGE BOOK LISTED U.S. PATENT FOR VALTOCO® (DIAZEPAM NASAL SPRAY) CIV
Published: 2023-11-27 (Crawled : 19:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
valtoco patent
ChromaDex to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
Published: 2023-10-31 (Crawled : 19:00) - biospace.com/
CDXC | $3.795 -4.41% -4.61% 200K
|
Process Industries
|
| O: -0.76%
H: 0.76%
C: 0.76%
report financial results
Regen BioPharma, Inc. Expects Second Phase of Confirmatory Study Shortly
Published: 2023-10-18 (Crawled : 19:00) - biospace.com/
RGBP | $0.5678 5.69% 2K
|
Manufacturing
|
| O: -2.78%
H: 5.71%
C: 2.86%
study
Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium
Published: 2023-10-16 (Crawled : 19:00) - biospace.com/
EQ | $1.77 -1.12% -1.13% 74K
|
Health Technology
|
| O: 4.21%
H: 5.5%
C: 2.35%
symposium presentation preclinical therapeutics
Halozyme Announces Positive Clinical Data of its High-Volume Auto-Injector Demonstrating Successful Rapid Subcutaneous Drug Delivery
Published: 2023-10-16 (Crawled : 19:00) - biospace.com/
HALO M | $37.84 -0.47% -0.48% 790K
|
Health Technology
|
| O: 1.01%
H: 0.68%
C: 0.24%
drug rapid positive
enVVeno Medical Achieves Full Enrollment for VenoValve U.S. Pivotal Trial
Published: 2023-10-06 (Crawled : 19:00) - biospace.com/
NVNO | $4.9 2.08% 2.04% 36K
|
Manufacturing
|
| O: 2.3%
H: 0.0%
C: -15.66%
venovalve medical trial
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 6, 2023
Published: 2023-09-06 (Crawled : 19:00) - biospace.com/
RGBP | $0.5678 5.69% 2K
|
Manufacturing
|
| O: -9.09%
H: 26.67%
C: 13.33%
conference growth
Dermata to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-08-31 (Crawled : 19:00) - biospace.com/
DRMA | $0.3316 12.45% 11.07% 280K
|
|
| O: -6.9%
H: 7.5%
C: 3.33%
conference global
New study finds continuing immunotherapy once cancer progresses doesn't work and could cause harm
Published: 2023-06-06 (Crawled : 19:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
work cancer immunotherapy study
Sonendo Announces New Leadership in Operations and R&D
Published: 2023-04-06 (Crawled : 19:00) - biospace.com/
SONX S | $0.092 3.6% 18K
|
Manufacturing
|
| O: -3.19%
H: 9.34%
C: 7.69%
DHR | $236.36 -1.27% 0.0% 4.2M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: -0.58%
sonendo
City of Hope appoints John D. Carpten, Ph.D., as director of its comprehensive cancer center and Beckman Research Institute, and chief scientific officer
Published: 2023-04-06 (Crawled : 19:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: -0.36%
H: 0.0%
C: 0.0%
hope cancer city research
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.